PROPRIETARY CLINICAL RECOGNITION METHODOLOGY
Earlier recognition. Built for clinical translation.
GentileX has developed a proprietary, clinician-guided methodology designed to identify when a “warrant to diagnose “ signals further evaluation by an Endo, for under-recognized male chromosomal and endocrine conditions, beginning with Klinefelter syndrome (47,XXY). We are now seeking the right strategic partner to take this to the next level and monetize this de-risked patent pending discovery and integrate it into clinical workflows . We have tested this with our first case study successfully and scoring 100 %.The case study was a complex one , and successfully warranted a diagnosis of 3 variants from 3 victims ,the Variants being : Classic Klinefelter Syndrome , Mosaic Klinefelter and Jacobs Syndrome .
From methodology to market
Methodology Developed
·
Clinical Validation
·
Strategic Partnership
·
Software Development
·
Workflow Integration
·
Methodology Developed · Clinical Validation · Strategic Partnership · Software Development · Workflow Integration ·
A Major Unmet Need
Many male endocrine and chromosomal conditions remain under-recognized or are identified only after significant clinical, developmental, fertility, or quality-of-life concerns emerge.
GentileX begins with Klinefelter syndrome because it provides a clear starting point for examining how earlier recognition may support more appropriate evaluation, care planning, and long-term health management.
